Search for the latest oncology news by tumour type
Diagnosis of ovarian cancer delayed by woeful lack of awareness
A global study of women with ovarian cancer has found that two thirds of women…
Browsing: Tumour Stream
Distinguishing fatal prostate cancer from ‘manageable’ cancer now possible
Scientists at the University of York have found a way of distinguishing between fatal prostate…
ESMO 2018: Women more prone to selected oesophagogastric cancer chemotherapy side-effects
Men and women may need to be treated differently – at least when it comes…
Brain cancer: why killing the fastest growing cells may not be the only treatment
Florian Siebzehnrubl, Cardiff University Brain cancers are fortunately rare tumours in adults. Nevertheless, the most…
Organic food and cancer risk – gut microbe expert on latest research
Tim Spector, King’s College London Organic food is an over-hyped and overpriced fad, according to…
Beating breast cancer only to die of opioid use – a sad Appalachian story
Rajesh Balkrishnan, University of Virginia The availability of life-prolonging treatments such as hormonal therapies and…
ESMO 2018: Shorter-course trastuzumab could be an option in HER2 positive early breast cancers
Women with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower…
ESMO 2018: One in six premenopausal early breast cancer patients do not adhere to hormonal therapy
Nearly one in six premenopausal women being treated for early stage breast cancer do not…
ESMO 2018: Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer
Epigenetic therapy with histone deacetylase (HDAC) inhibitors is worth pursuing in hormone receptor positive advanced…
ESMO 2018: New option for women with advanced breast cancer resistant to hormone therapy
Treatment with the cyclin dependent kinase (CDK) 4/6 inhibitor palbociclib achieves a clinically meaningful improvement…